Clemens van Blitterswijk is a Venture Partner in the EQT Life Sciences team. Clemens worked for LSP from 2012 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences.
Clemens also holds a distinguished professorship at Maastricht University where he served as general director of the MERLN institute for regenerative medicine and is figurehead of Regmed XB, which he co-founded.
After obtaining an MSc. in cell biology at Leiden University, Clemens received a PhD at the faculty of medicine at the same institution.